Venus Medtech (Hangzhou) Inc.
VMTHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $35 | $34 | $5,014 | $13,373 |
| - Cash | $298 | $774 | $1,879 | $2,955 |
| + Debt | $369 | $826 | $900 | $71 |
| Enterprise Value | $106 | $85 | $4,034 | $10,488 |
| Revenue | $471 | $491 | $406 | $416 |
| % Growth | -4.2% | 20.9% | -2.3% | – |
| Gross Profit | $368 | $389 | $314 | $324 |
| % Margin | 78.1% | 79.2% | 77.3% | 78% |
| EBITDA | -$613 | -$548 | -$999 | -$324 |
| % Margin | -130.2% | -111.5% | -245.9% | -77.9% |
| Net Income | -$714 | -$704 | -$1,058 | -$374 |
| % Margin | -151.7% | -143.2% | -260.2% | -89.8% |
| EPS Diluted | -1.63 | -1.61 | -2.42 | -0.85 |
| % Growth | -1.2% | 33.5% | -184.7% | – |
| Operating Cash Flow | $24 | -$610 | -$729 | -$457 |
| Capital Expenditures | -$42 | -$263 | -$179 | -$145 |
| Free Cash Flow | -$18 | -$873 | -$908 | -$602 |